The global 3D Bioprinting Market is expected to reach USD 2,687.8 million by 2027, according to a new report by Emergen Research. The growth of this market can be attributed to the technological developments of the 3D bioprinters and growing funding of the private and public organizations to encourage bioprinting research. Increasing investments in research and development of regenerative medicines and stem cell research is augmenting the demand for the industry.
The research in the global 3D Bioprinting market is conducted by skilled professionals around various regions and industry groups. Te 3D Bioprinting market research provides both qualitative and quantitative assessment and highlights the challenges and growth drivers in various segments of the market. It also reflects the opportunities in various sectors of the Enterprise High-Productivity Application Platform market.
You Can Download Free Sample PDF Copy of 3D Bioprinting Market at https://www.emergenresearch.com/request-sample/133
North America dominated the market with a revenue share of 48.1% in 2019, owing to the presence of technologically advanced healthcare infrastructure and uninterrupted initiatives of the government to enhance the healthcare industry.
Asia-Pacific is expected to witness the highest CAGR over the forecast period due to the increasing demand for organ transplants, cosmetic surgeries, and lack of organ donors. Besides, the increasing investments of the government in the research and development of the vaccine due to the growing cases of COVID-19 is expected to fuel the demand for the 3D bioprinting in the region.
Key participants include Allevi Inc., Organovo Holdings, Inc., CELLINK, Aspect Biosystems Ltd., Cyfuse Biomedical K.K., EnvisionTEC GmbH, TeVido BioDevices, Poietis, Digilab, Inc., and Nano3D Biosciences, Inc, among others.
Technology Outlook (Revenue, USD Billion; 2017-2027)
Laser-based
Inkjet-based
Syringe-based
Magnetic Levitation
Others
Material Outlook (Revenue, USD Billion; 2017-2027)
Hydrogels
Living Cells
Extracellular Matrices
Application Outlook (Revenue, USD Billion; 2017-2027)
Clinical Application ( Blood Vessels, Skin)
Research Application (Regenerative Medicine, 3D Cell Culture, Drug research)
The global 3D Bioprinting market is classified on a product basis, application and end-user. Based on product, the market is segmented as systems, and services & software. Considering application the market is classified as cardiology, oncology, neurology, and others. The market on the basis of the end-user is classified as hospitals, ambulatory surgical centers, and diagnostic centers.
Regional Outlook (Revenue, USD Billion; 2017-2027)
North America (U.S., Canada)
Europe (U.K., Italy, Germany, France, Rest of EU)
Asia Pacific (India, Japan, China, South Korea, Australia, Rest of APAC)
Latin America (Chile, Brazil, Argentina, Rest of Latin America)
Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of MEA)
Market Competitiveness:
Owing to the huge demand for the 3D Bioprinting product, key players operating in the market relish on economies of scale. Due to a large number of partnerships and collaborations, the demand for the 3D Bioprinting product has risen at a considerable rate. However, the new entrants in the market are in an effort to increase their partnerships with the OEMs, which will result in an increased market share over the coming years. On the other hand, companies are also investing heavily in interoperability, which is expected to intensify the market competition during the forecast period.
Here are the questions we answer…
What are the future opportunities in store for the vendors operating in the 3D Bioprinting market?
What does the competitive landscape look like?
Which emerging technologies are believed to impact the 3D Bioprinting market performance?
What are the key trends and dynamics?
Which regulations that will impact the industry?
Which segment will offer the most opportunity for growth between 2020 and 2027?
Where will most developments take place in the long term?
Who are the most prominent vendors and how much market share do they occupy?
What are the latest technologies or discoveries influencing the 3D Bioprinting market growth worldwide?
Read more@ https://www.emergenresearch.com/industry-report/3d-bioprinting-market
Table of Content
Chapter 1. 3D Bioprinting Market Methodology & Sources
1.1. 3D Bioprinting Market Definition
1.2. 3D Bioprinting Market Research Scope
1.3. 3D Bioprinting Market Methodology
1.4. 3D Bioprinting Market Research Sources
1.4.1. Primary
1.4.2. Secondary
1.4.3. Paid Sources
1.5. Market Estimation Technique
Chapter 2. Executive Summary
2.1. Summary Snapshot, 2019-2027
Chapter 3. 3D Bioprinting Market Key Insights
Chapter 4. 3D Bioprinting Market Segmentation & Impact Analysis
Chapter 5. 3D Bioprinting Market By Products Insights & Trends, Revenue (USD Million), Volume (Kilo Tons)
Chapter 6. 3D Bioprinting Market By Types Insights & Trends, Revenue (USD Million), Volume (Kilo Tons)
Chapter 7. 3D Bioprinting Market By Applications Insights & Trends Revenue (USD Million), Volume (Kilo Tons)
Chapter 8. 3D Bioprinting Market By End Use Insights & Trends Revenue (USD Million), Volume (Kilo Tons)
Chapter 9. 3D Bioprinting Market Regional Outlook
Chapter 10. Competitive Landscape
Continued…
Media ContactCompany Name: Emergen ResearchContact Person: Eric LeeEmail: Send EmailPhone: +1 (604) 757-9756Address:14671 110 Avenue Surrey, British Columbia, V3R2A9City: SurreyState: British ColumbiaCountry: CanadaWebsite: https://www.emergenresearch.com/industry-report/3d-bioprinting-market